Gilead Says HIV 'No Generic' Suit Is Baseless
The
complaint alleges the scheme allowed Gilead to earn $59 billion on HIV drugs
in the U.S. between 2004 and 2017 despite developing only a ...
|
View article...
Updates & Legacy — Stigmabase is a Canadian Non-Governmental & Nonprofit Initiative. Our mission is to inform about stigma around the world and make the data collected accessible for researchers. Stigmabase is very attentive to misinformation and lists only reliable sources. — The marginalization of individuals or categories of individuals is a too common phenomenon. Millions of people are facing this problem around the world and many complex factors are involved.
The
complaint alleges the scheme allowed Gilead to earn $59 billion on HIV drugs
in the U.S. between 2004 and 2017 despite developing only a ...
|